Fondevilla A, Serradilla A, Moreno-Olmedo E, Matskov K, Belmonte MJ,
Sáez A, Acevedo MJ, López E. Radiochemotheraphy-induced oral mucositis: Ectoin
solution as a new treatment. J Clin Exp Dent. 2022;14(5):e433-8.
doi:10.4317/jced.59110
https://doi.org/10.4317/jced.59110
___________
References
|
1.
Adriana Fondevilla, José Luis López-Guerra, Samaniego Conde MA, Belmonte
González MJ, Praena-Fernandez JM, et al. Outcome and toxicity of intensity
modulated radiotherapy with simultaneous integrated boost in patients with
pharyngo-laryngeal cancer. Clin Transl Oncol. 2019;21:881-890. |
|
|
|
|
|
2.
Nutting CM, Morden JP, Harrington KJ, Guerrero Urbano T, Bhide SA, Clark C,
et al. Parotid-sparing intensity modulated versus conventional radiotherapy
in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled
trial. Lancet Oncol. 2011;12:127-136. PMid:21236730
PMCid:PMC3033533 |
|
|
|
|
|
3.
Ahmed Esmat Abdel Moneim, Ana Guerra-Librero, Shen YQ, Fernández-Gil B,
Acuña-Castroviejo D, et al. Oral Mucositis: Melatonin Gel an Effective New
Treatment. Review. Int J Mol Sci 2017;18:1003. |
|
|
|
|
|
4.
Tomoya Yokota, Tsuyoshi Onoe, Hirofumi Ogawa, Hamauchi S, Iida Y, Kamijo T, et
al. Distinctive mucositis and feeding-tube dependency in cetuximab plus
radiotherapy for head and neck cancer. Jpn J Clin Oncol Actions. 2015 Feb;
45:183-8. |
|
|
|
|
|
5.
James A, Bonner, Jordi Giralt, Paul M Harari, Baselga J, Spencer S, Bell D,
et al. Association of human papillomavirus and p16 status with mucositis and
dysphagia for head and neck cancer patients treated with radiotherapy with or
without cetuximab: Assessment from a phase 3 registration trial. Eur J
Cancer. 2016;64:1-11. |
|
|
|
|
|
6.
Hahn MB, Meyer S, Schröter MA, Kunte HJ, Solomun T, Sturm H. DNA protection
by ectoine from ionizing radiation: molecular mechanisms. Phys Chem Chem
Phys. 2017;19:25717-25722. |
|
|
|
|
|
7.
Schröter MA, Meyer S, Hahn MB, Solomun T, Sturm H, Kunte HJ. Ectoine protects
DNA from damage by ionizing radiation. Sci Rep. 2017;7:15272. |
|
|
|
|
|
8.
Dao VA, Bilstein A, Overhagen S, Géczi L, Baráth Z, Mösges R. Effectiveness,
Tolerability, and Safety of Ectoine Containing Mouthwash Versus Those of a
Calcium Phosphate Mouthwash for the Treatment of Chemotherapy-Induced Oral
Mucositis: A Prospective, Active-Controlled, Non-interventional Study. Oncol
Ther. 2018;6:59-72. |
|
|
|
|
|
9.
ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine
(US). Identifier NCT02816515. Non Interventional Clinical Investigation of
Ectoin® |
|
|
|
|
|
10.
Mouth Wash for the Prevention and Treatment of Chemotherapy-induced Oral
Mucositis. 2017. https://clinicaltrials.gov/ct2/show/record/NCT02816515. |
|
|
|
|
|
11.
Alvariño-Martín C, Sarrión-Pérez MG. Prevention and treatment of oral
mucositis in patients receiving chemotherapy. J Clin Exp Dent. 2014;6:74-80. |
|
|
|
|
|
12.
Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy
Oncology Group (RTOG) and the European Organization for Research and
Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31:1341-1346. PMid:7713792 |
|
|
|
|
|
13.
Koksel Y, Gencturk M, Spano A, Reynolds M, Roshan S, Caycı Z. Utility of
Likert scale (Deauville criteria) in assessment of Chemoradiotherapy response
of primary oropharyngeal squamous cell Cancer site. Clin Imaging. 2019;55:89-94. |
|
|
|
|
|
14.
Murphy BA, Beaumont JL, Isitt J, Garden AS, Gwede CK, Trotti AM, et al.
Mucositis-related morbidity and resource utilization in head and neck cancer
patients receiving radiation therapy with or without chemotherapy. J Pain
Symptom Manage. 2009;38:522-532. |
|
|
|
|
|
15.
Marta GN, Silva V, de Andrade Carvalho H, de Arruda FF, Hanna SA, Gadia R, et
al. Intensity-modulated radiation therapy for head and neck cancer:
systematic review and meta-analysis. Radiother Oncol. 2014;110:9-15. |
|
|
|
|
|
16.
J. L. Menguall, J. L. Monroy, A. Fondevilla, Cañón R, Vázquez G, Santos M, et
al. Estudio epidemiológico observacional prospectivo del manejo del dolor en
pacientes oncológicos en tratamiento radioterápico: estudio GORVAMUR. Rev Soc
Esp Dolor. 2017;24:241-55. |
|
|
|
|
|
17.
Lalla RV, Sonis ST, Peterson DE. Management of oral mucositis in patioents
who have cancer. Dent Clin N Am. 2008;52:61-77. |
|
|
|
|
|
18.
Villa A, Sonis ST. Mucositis: Pathobiology and management. Curr Opin Oncol.
2015;27:159-64. |
|
|
|
|
|
19.
Henry W C Leung, Agnes L F Chan. Glutamine in alleviation of
Radiation-induced Severe oral mucositis: A meta-analysis. Nutr Cancer.
2016;68:734-42. |
|
|
|
|
|
20.
Huang CJ, Huang MY, Fang PT. Randomized double-blind, placebo-controlled
trial evaluating oral glutamine on radiation-induced oral mucositis and
dermatitis in head and neck cancer patients. Am J Clin Nutr. 2019;109:606-14. |
|
|
|
|
|
21.
Peralta-Mamani M, Machado da Silva B, da Silva Pinto AC, Regina Fischer
Rubira-Bullen I, Marques Honório H, Fischer Rubira CM, et al. Low-level laser
therapy dosimetry most used for oral mucositis due to radiotherapy for head
and neck cancer: a systematic review and meta-analysis. Crit Rev Oncol
Hematol. 2019;138:14-23.19 |
|
|
|
|
|
22.
Rieckmann T, Gatzemeier F, Christiansen S, Rothkamm K, Münscher A. The
inflammation-reducing compatible solute ectoine does not impair the cytotoxic
effect of ionizing radiation on head and neck cancer cells. Sci Rep. 2019;9:6594.
|
|
|
|
|
|
23.
Brewczyński A, Jabłońska B, Mrowiec S, Składowski K, Rutkowski T. Nutritional
Support in Head and Neck Radiotherapy Patients Considering HPV Status.
Nutrients. 2020;13: 57. |
|
|
|
|
|
24.
Friedes C, Klingensmith J, Nimo N, Gregor J, Burri R. Late Feeding Tube
Dependency in Head and Neck Cancer Patients Treated with Definitive Radiation
Therapy and Concurrent Systemic Therapy. Cureus. 2020;12:e7683. |
|